189 related articles for article (PubMed ID: 33505228)
1. Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on
Li CP; Liu DN; Zhou NN; Tian XY; Wang Z; Liu BN; Hao CY
Contrast Media Mol Imaging; 2021; 2021():7191363. PubMed ID: 33505228
[TBL] [Abstract][Full Text] [Related]
2. Maximum standardized uptake value on
Rhu J; Hyun SH; Lee KH; Jo SJ; Lee KW; Park JB; Kim SJ
Sci Rep; 2019 Apr; 9(1):6605. PubMed ID: 31036901
[TBL] [Abstract][Full Text] [Related]
3. Which modality is better to diagnose high-grade transformation in retroperitoneal liposarcoma? Comparison of computed tomography, positron emission tomography, and magnetic resonance imaging.
Nakashima Y; Yokoyama Y; Ogawa H; Sakakibara A; Sunagawa M; Nishida Y; Mizuno T; Yamaguchi J; Onoe S; Watanabe N; Kawakatsu S; Igami T; Ebata T
Int J Clin Oncol; 2023 Mar; 28(3):482-490. PubMed ID: 36583836
[TBL] [Abstract][Full Text] [Related]
4. The role of
Subramaniam S; Callahan J; Bressel M; Hofman MS; Mitchell C; Hendry S; Vissers FL; Van der Hiel B; Patel D; Van Houdt WJ; Tseng WW; Gyorki DE
J Surg Oncol; 2021 Mar; 123(4):1081-1087. PubMed ID: 33444466
[TBL] [Abstract][Full Text] [Related]
5. Preoperative assessment of retroperitoneal Liposarcoma using volume-based
Liu DN; Wu JH; Li ZW; Wang HY; Tian XY; Hao CY
BMC Med Imaging; 2023 Dec; 23(1):215. PubMed ID: 38110909
[TBL] [Abstract][Full Text] [Related]
6. The Role of Preoperative
Jo SJ; Kim KD; Lim SH; Kim J; Hyun SH; Park JB; Lee KW
Front Oncol; 2022; 12():868823. PubMed ID: 35712466
[No Abstract] [Full Text] [Related]
7. Computed tomography scan-driven selection of treatment for retroperitoneal liposarcoma histologic subtypes.
Lahat G; Madewell JE; Anaya DA; Qiao W; Tuvin D; Benjamin RS; Lev DC; Pollock RE
Cancer; 2009 Mar; 115(5):1081-90. PubMed ID: 19156920
[TBL] [Abstract][Full Text] [Related]
8. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.
Parkes A; Urquiola E; Bhosale P; Lin H; Watson K; Wang WL; Feig B; Torres K; Roland CL; Conley AP; Zarzour M; Livingston JA; Ratan R; Ludwig J; Araujo DM; Ravi V; Benjamin RS; Patel S; Somaiah N
Sarcoma; 2020; 2020():8363986. PubMed ID: 32565716
[TBL] [Abstract][Full Text] [Related]
9. Intense FDG Uptake in Well-Differentiated Inflammatory Liposarcoma of the Retroperitoneum.
Zhao Q; Dong A; Zuo C; Fang Y
Clin Nucl Med; 2024 Jul; 49(7):685-687. PubMed ID: 38598478
[TBL] [Abstract][Full Text] [Related]
10. The value of multiparameter
Jiang Y; Hou G; Zhu Z; Huo L; Cheng W; Li F
Sci Rep; 2020 Jul; 10(1):12887. PubMed ID: 32732920
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous pulmonary and inferior vena cava tumor thromboembolism secondary to retroperitoneal pleomorphic liposarcoma.
Chen C; Jiang C; Li L
Hell J Nucl Med; 2018; 21(1):74-76. PubMed ID: 29550849
[TBL] [Abstract][Full Text] [Related]
12. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography manifestations of histologic subtypes of retroperitoneal liposarcoma.
Lu J; Qin Q; Zhan LL; Yang X; Xu Q; Yu J; Dou LN; Zhang H; Yang Y; Chen XC; Yang YH; Cheng HY; Sun XC
Asian Pac J Cancer Prev; 2014; 15(15):6041-6. PubMed ID: 25124571
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a diagnostic
Lim CH; Seok HY; Hyun SH; Moon SH; Cho YS; Lee KH; Kim BT; Choi JY
Clin Radiol; 2019 Mar; 74(3):207-215. PubMed ID: 30638733
[TBL] [Abstract][Full Text] [Related]
15. Round cell liposarcoma presenting as an FDG-positive primary with an FDG-negative retroperitoneal metastasis: a pitfall for F-18 FDG PET/CT imaging.
Rakheja R; Makis W; Nahal A; Alabed YZ; Abikhzer G; Probst S; Hickeson M
Clin Nucl Med; 2011 Dec; 36(12):e213-6. PubMed ID: 22064114
[No Abstract] [Full Text] [Related]
16. Head-to-head evaluation of [
Gu B; Liu X; Wang S; Xu X; Liu X; Hu S; Yan W; Luo Z; Song S
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2889-2901. PubMed ID: 35113192
[TBL] [Abstract][Full Text] [Related]
17. [The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall].
Yamamoto H; Sugimoto S; Miyoshi K; Yamamoto H; Soh J; Yamane M; Toyooka S; Oto T; Miyoshi S
Kyobu Geka; 2014 Jan; 67(1):4-8. PubMed ID: 24743405
[TBL] [Abstract][Full Text] [Related]
18. Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET.
Benz MR; Dry SM; Eilber FC; Allen-Auerbach MS; Tap WD; Elashoff D; Phelps ME; Czernin J
J Nucl Med; 2010 Aug; 51(8):1174-81. PubMed ID: 20660389
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S
BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma.
Wakamatsu T; Imura Y; Tamiya H; Yagi T; Yasuda N; Nakai S; Nakai T; Outani H; Hamada K; Kakunaga S; Araki N; Ueda T; Takenaka S
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
